For European animal health companies
A market that looks familiar, and is not
Built for European animal health companies entering or expanding in the United States.
U.S. Market Entry
European animal health companies entering the United States meet a market that looks familiar and is not. Distribution is structured differently, the boundary between a medical claim and a marketing statement sits in a different place, and the veterinary buying process follows its own logic. We map that before the first dollar is committed, then build a U.S. commercial story rather than translating the European one.
Market & Distribution Mapping
Claim & Regulatory Boundaries
A U.S. Commercial Story
Launch Sequencing
Who this is for
European animal health companies preparing a first U.S. launch.
Companies already selling in the U.S. through a distributor and not getting traction.
Boards and investors underwriting a U.S. expansion case.
What usually goes wrong
The European commercial story gets translated rather than rebuilt. The claim set that cleared one regulator is assumed to clear another. Distribution is treated as a logistics question when it is a positioning question. Each of those is cheaper to find before the first dollar is committed than after.
Discuss U.S. Market EntryLet’s Connect
Ready to start a conversation?
Tell us the company, the stage, what you are trying to accomplish and your timeline. Four fields, and Dr. Burns replies personally within a day.